# FDA Inspection 860780 - Liquipak Corp. - December 20, 2013

Source: https://www.keypedia.com/records/fda_inspections/liquipak-corp/7cfcb743-9161-4f47-936c-841e22fa29ac
Source feed: FDA_Inspections

> FDA Inspection 860780 for Liquipak Corp. on December 20, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 860780
- Company Name: Liquipak Corp.
- Inspection Date: 2013-12-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287196 - 2025-10-16](https://www.keypedia.com/records/fda_inspections/liquipak-corp/a5d487a0-1edf-4f55-b357-04d3e9ca72e0)
- [FDA Inspection 1070634 - 2018-11-01](https://www.keypedia.com/records/fda_inspections/liquipak-corp/9b7414fd-2a24-41d6-9c41-1a07b9559122)

Company: https://www.keypedia.com/companies/liquipak-corp/d2b2f45d-157b-4209-bb6b-ba9e7b47c059

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c